CWM LLC lowered its stake in Aehr Test Systems (NASDAQ:AEHR - Free Report) by 95.6% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,269 shares of the semiconductor company's stock after selling 114,086 shares during the period. CWM LLC's holdings in Aehr Test Systems were worth $38,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Invesco Ltd. increased its position in shares of Aehr Test Systems by 7.9% during the fourth quarter. Invesco Ltd. now owns 16,007 shares of the semiconductor company's stock worth $266,000 after purchasing an additional 1,172 shares in the last quarter. JPMorgan Chase & Co. increased its position in Aehr Test Systems by 15.4% during the fourth quarter. JPMorgan Chase & Co. now owns 15,591 shares of the semiconductor company's stock worth $259,000 after buying an additional 2,076 shares during the period. Rhumbline Advisers increased its position in Aehr Test Systems by 5.7% during the first quarter. Rhumbline Advisers now owns 40,212 shares of the semiconductor company's stock worth $293,000 after buying an additional 2,165 shares during the period. Dimensional Fund Advisors LP lifted its stake in Aehr Test Systems by 1.8% in the fourth quarter. Dimensional Fund Advisors LP now owns 137,241 shares of the semiconductor company's stock valued at $2,283,000 after buying an additional 2,365 shares during the last quarter. Finally, State of Wyoming purchased a new position in Aehr Test Systems during the 4th quarter worth $67,000. 69.69% of the stock is owned by institutional investors and hedge funds.
Aehr Test Systems Trading Down 2.9%
Shares of AEHR traded down $0.55 during mid-day trading on Tuesday, hitting $18.48. The company's stock had a trading volume of 781,075 shares, compared to its average volume of 2,114,080. The firm has a 50-day simple moving average of $14.18 and a 200 day simple moving average of $11.04. The firm has a market capitalization of $552.92 million, a P/E ratio of -142.14 and a beta of 2.35. Aehr Test Systems has a 1-year low of $6.27 and a 1-year high of $23.00.
Aehr Test Systems (NASDAQ:AEHR - Get Free Report) last announced its quarterly earnings data on Tuesday, July 8th. The semiconductor company reported ($0.01) EPS for the quarter, beating the consensus estimate of ($0.02) by $0.01. Aehr Test Systems had a negative net margin of 6.63% and a negative return on equity of 0.15%. The firm had revenue of $14,100 billion during the quarter, compared to analysts' expectations of $14.83 million. As a group, sell-side analysts predict that Aehr Test Systems will post 0.1 EPS for the current fiscal year.
Wall Street Analyst Weigh In
Separately, Wall Street Zen raised Aehr Test Systems to a "sell" rating in a report on Tuesday, May 13th.
Read Our Latest Stock Analysis on AEHR
Insider Transactions at Aehr Test Systems
In related news, VP Alistair N. Sporck sold 3,000 shares of the stock in a transaction dated Tuesday, July 15th. The shares were sold at an average price of $14.13, for a total value of $42,390.00. Following the sale, the vice president directly owned 30,808 shares of the company's stock, valued at approximately $435,317.04. This represents a 8.87% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Rhea J. Posedel sold 18,000 shares of the stock in a transaction on Tuesday, July 22nd. The shares were sold at an average price of $19.83, for a total value of $356,940.00. Following the sale, the director owned 71,163 shares in the company, valued at approximately $1,411,162.29. This trade represents a 20.19% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 30,995 shares of company stock worth $552,185. Corporate insiders own 6.20% of the company's stock.
Aehr Test Systems Company Profile
(
Free Report)
Aehr Test Systems provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, and package part form, and installed systems worldwide. Its product portfolio includes FOX-XP and FOX-NP systems that are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize range of devices, including silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices.
See Also

Before you consider Aehr Test Systems, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aehr Test Systems wasn't on the list.
While Aehr Test Systems currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.